What is Immunome's shares (diluted)?

Immunome (IMNM) reported shares (diluted) of 113.1M in Q1 2026.

How has Immunome's shares (diluted) changed year-over-year?

Immunome's shares (diluted) increased by 42.5% year-over-year, from 79.4M to 113.1M.

What is the long-term trend for Immunome's shares (diluted)?

Over 4 years (2021 to 2025), Immunome's shares (diluted) has grown at a 65.5% compound annual growth rate (CAGR), from 45.6M to 341.7M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Immunome IMNM Shares (Diluted)

Shares (Diluted) at other companies

PfizerPFE

5.7B+0.4%

Arcus BiosciencesRCUS

125.4M+27.4%

Nuvation BioNUVB

377.5M+11.5%

SELLAS Life Sciences Group, Inc.SLS

172.5M+96.5%

IDEAYA Biosciences, Inc.IDYA

88.7M+0.4%

ImmunityBio, Inc.IBRX

1B+20.4%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's shares (diluted)?: Immunome (IMNM) reported shares (diluted) of 113.1M in Q1 2026.
How has Immunome's shares (diluted) changed year-over-year?: Immunome's shares (diluted) increased by 42.5% year-over-year, from 79.4M to 113.1M.
What is the long-term trend for Immunome's shares (diluted)?: Over 4 years (2021 to 2025), Immunome's shares (diluted) has grown at a 65.5% compound annual growth rate (CAGR), from 45.6M to 341.7M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.